Newsbenzinga
FDA OKs Sanofi Diabetes Drug In Newly Diagnosed Pediatric Patients
· Published
Article summary
FDA grants accelerated approval to Sanofi Tzield for children with newly diagnosed stage 3 type 1 diabetes, backed by Phase 3 data.
An excerpt from the original article.
Comments —
Loading comments…